Enbrel "Dear Doctor" Letter Possible Following Hematologic Adverse Events
FDA and Immunex are discussing the possibility of a "Dear Doctor" letter for Enbrel to provide an update on postmarketing adverse reactions.
FDA and Immunex are discussing the possibility of a "Dear Doctor" letter for Enbrel to provide an update on postmarketing adverse reactions.